Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22689805

Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2012 Jul 20
First author
Kantarjian HM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2013 Feb 20;31(6):820-1. doi: 10.1200/JCO.2012.45.2219.
    note
    Source null
    related pmid
    23129743
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2013 Feb 20;31(6):822-3. doi: 10.1200/JCO.2012.46.4222.
    note
    Source null
    related pmid
    23129745
    relationship
    Comment in

Authors and identifiers

  1. name
    Kantarjian HM
    type
    Author
  2. name
    Thomas XG
    type
    Author
  3. name
    Dmoszynska A
    type
    Author
  4. name
    Wierzbowska A
    type
    Author
  5. name
    Mazur G
    type
    Author
  6. name
    Mayer J
    type
    Author
  7. name
    Gau JP
    type
    Author
  8. name
    Chou WC
    type
    Author
  9. name
    Buckstein R
    type
    Author
  10. name
    Cermak J
    type
    Author
  11. name
    Kuo CY
    type
    Author
  12. name
    Oriol A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kantarjian HM
    type
    Author
  2. name
    Thomas XG
    type
    Author
  3. name
    Dmoszynska A
    type
    Author
  4. name
    Wierzbowska A
    type
    Author
  5. name
    Mazur G
    type
    Author
  6. name
    Mayer J
    type
    Author
  7. name
    Gau JP
    type
    Author
  8. name
    Chou WC
    type
    Author
  9. name
    Buckstein R
    type
    Author
  10. name
    Cermak J
    type
    Author
  11. name
    Kuo CY
    type
    Author
  12. name
    Oriol A
    type
    Author
bibliography ids
  1. nci-bib-793a54168278233543382e3d
book metadata
content sha256
27cca21c9c20f92543c372d4b8568554d51f4fc790096b32e4f3d56a482f4daa
document type
citation
dois
  1. 10.1200/JCO.2011.38.9429
electronic publication date
display
2012 Jun 11
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22689805
immutable id
pubmed:22689805@27cca21c9c20f92543c372d4b8568554d51f4fc790096b32e4f3d56a482f4daa
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
21
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2670-7
volume
30
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2013 Feb 20;31(6):820-1. doi: 10.1200/JCO.2012.45.2219.
    note
    Source null
    related pmid
    23129743
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2013 Feb 20;31(6):822-3. doi: 10.1200/JCO.2012.46.4222.
    note
    Source null
    related pmid
    23129745
    relationship
    Comment in
outcomes validated
false
pmid
22689805
provenance
batch id
c95be1d0b8cf19942816
provider
NCBI PubMed ESummary
record sha256
bf6155f9f1cbdc47adc172a30f9bacff588f5d00c83ea99972da0285017beb30
response sha256
a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
retrieved at
2026-09-09T23:46:47.691937+00:00
publication date
display
2012 Jul 20
precision
day
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22689805/
title
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.

Preserved source evidence · Not medical advice